Nebulized furosemide

DRUG2 trials

Sponsors

Dr. John Muscedere, Medical Research Institute Alexandria University

Conditions

Covid19RespiratoryRespiratory Failure

Phase 2

Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

TerminatedNCT04588792

Dr. John MuscedereCovid19, Respiratory Failure

Start: 2021-04-16End: 2023-04-30Updated: 2023-12-11

Unknown Phase

Nebulized furosemide as adjunctive therapy in patients with stable chronic obstructive pulmonary disease : A randomized controlled trial

Active, not recruitingPACTR202106917652038

Medical Research Institute Alexandria UniversityRespiratory

Start: 2021-07-01Target: 100Updated: 2026-01-27